Author Topic: (Abst.) Age and the risks of high-efficacy DMDs in MS  (Read 5 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8134
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Age and the risks of high-efficacy DMDs in MS
« on: April 17, 2019, 02:42:04 pm »
From PubMed (April 16, 2019), "Age and the risks of high-efficacy disease-modifying drugs in multiple sclerosis":


https://www.ncbi.nlm.nih.gov/pubmed/30985373
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
36 Views
Last post April 10, 2017, 09:08:52 pm
by agate
0 Replies
41 Views
Last post April 26, 2017, 07:09:59 am
by agate
0 Replies
34 Views
Last post November 17, 2017, 09:11:56 pm
by agate
0 Replies
30 Views
Last post April 01, 2018, 01:43:26 pm
by agate
0 Replies
7 Views
Last post May 11, 2019, 02:32:11 pm
by agate